0001387131-16-005689.txt : 20160526 0001387131-16-005689.hdr.sgml : 20160526 20160526120807 ACCESSION NUMBER: 0001387131-16-005689 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160525 FILED AS OF DATE: 20160526 DATE AS OF CHANGE: 20160526 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ohr Pharmaceutical Inc CENTRAL INDEX KEY: 0001173281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465622433 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 800 THIRD AVENUE STREET 2: 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 682-8452 MAIL ADDRESS: STREET 1: 800 THIRD AVENUE STREET 2: 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: BBM HOLDINGS, INC. DATE OF NAME CHANGE: 20070402 FORMER COMPANY: FORMER CONFORMED NAME: PRIME RESOURCE INC DATE OF NAME CHANGE: 20020513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Slakter Jason Scott CENTRAL INDEX KEY: 0001630109 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35963 FILM NUMBER: 161677022 MAIL ADDRESS: STREET 1: 57 MEADOW WOODS ROAD CITY: GREAT NECK STATE: NY ZIP: 11020 4 1 slakter-form4_052516.xml OWNERSHIP DOCUMENT X0306 4 2016-05-25 0 0001173281 Ohr Pharmaceutical Inc OHRP 0001630109 Slakter Jason Scott C/O OHR PHARMACEUTICAL INC. 800 THIRD AVE, 11TH FLOOR NEW YORK NY 10022 1 1 0 0 Chief Executive Officer Common Stock, par value $0.0001 per share 2016-05-25 4 P 0 500 3.09 A 913072 D Common Stock, par value $0.0001 per share 2016-05-25 4 P 0 100 3.11 A 913172 D Common Stock, par value $0.0001 per share 2016-05-25 4 P 0 300 3.14 A 913472 D Common Stock, par value $0.0001 per share 2016-05-25 4 P 0 100 3.1399 A 913572 D Common Stock, par value $0.0001 per share 2016-05-25 4 P 0 682 3.13 A 914254 D Common Stock, par value $0.0001 per share 2016-05-25 4 P 0 2000 3.10 A 916254 D Common Stock, par value $0.0001 per share 697865 I By SKS Ocular I LLC SKS Ocular I LLC directly owns the shares of Common Stock. On May 30, 2014, the Issuer completed an ophthalmology assets acquisition of SKS Ocular LLC and SKS Ocular I LLC. Pursuant to the acquisition agreement, among other things, SKS Ocular I LLC is eligible to receive additional shares of Common Stock in three contingent milestone payments. Milestone 1 has been met and on December 15, 2015, the Issuer issued 497,859 shares of Common Stock to SKS Ocular I LLC. The Reporting Person has investment and voting power with respect to the Common Stock held by SKS Ocular 1 LLC. Therefore, the Reporting Person may be deemed to beneficially own the shares of Common Stock beneficially owned by SKS Ocular 1 LLC. The Reporting Person disclaims any beneficial ownership of the Common Stock directly owed by SKS Ocular I LLC except to the extent of his pecuniary interest therein. /s/ Jason Scott Slakter 2016-05-26